Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(+)-3-(4-Chlorophenyl)-N'-[(4-cyanophenyl)sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine | 219565 | UNDEFINED | 0 | Human | Binding | pKi | = | 10000.00 | 5.00 | -3467 | 5 | - | PDSP KiDatabase | 463.1 | 4 | 1 | 4 | 3.72 | N#Cc1ccc(S(=O)(=O)N=C(N)N2CC(c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1 | - | |
(+)-chlorpheniramine | 918 | None | 42 | Human | Binding | pKi | = | 5.08 | 8.29 | -446 | 27 | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | Drug Central | 274.1 | 5 | 0 | 2 | 3.82 | CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 | - | |
(+)-chlorpheniramine | 918 | None | 42 | Human | Binding | AC50 | = | 412.30 | 6.38 | -446 | 27 | Binding affinity towards human HRH2 in an in vitro assay with cellular components measured by membrane filtration | ChEMBL | 274.1 | 5 | 0 | 2 | 3.82 | CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
(+)-chlorpheniramine | 918 | None | 42 | Human | Binding | Ki | = | 8228.00 | 5.08 | -446 | 27 | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | ChEMBL | 274.1 | 5 | 0 | 2 | 3.82 | CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 | - | |
(+)-chlorpheniramine | 918 | None | 42 | Human | Binding | IC50 | = | 8368.00 | 5.08 | -446 | 27 | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | ChEMBL | 274.1 | 5 | 0 | 2 | 3.82 | CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 | - | |
(-)-stepholidine | 3691 | 3H-TIOTIDINE | 40 | Human | Binding | pKi | = | 10000.00 | 5.00 | -2290 | 35 | - | PDSP KiDatabase | 327.1 | 2 | 2 | 5 | 2.77 | COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2 | - | |
(1R,2S)-PHENYLPROPANOLAMINE | 27120 | 3H-TIOTIDINE | 13 | Human | Binding | pKi | = | 10000.00 | 5.00 | -38 | 42 | - | PDSP KiDatabase | 151.1 | 2 | 2 | 2 | 1.07 | C[C@H](N)[C@H](O)c1ccccc1 | - | |
4-methylhistamine | 121 | None | 34 | Human | Binding | Ki | = | 7943.28 | 5.10 | -269 | 7 | Displacement of [125I]iodoaminopotentidine from human histamine H2 receptor expressed in CHO cells | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
4-methylhistamine | 121 | 3H-TIOTIDINE | 34 | Guinea pig | Binding | pKi | = | 10000.00 | 5.00 | -338 | 7 | - | PDSP KiDatabase | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | - | |
A-304121 | 196 | None | 15 | Human | Binding | Ki | = | 70794.58 | 4.15 | -35481 | 5 | Binding affinity towards Histamine H2 receptor from human membranes | ChEMBL | 359.2 | 8 | 1 | 5 | 1.54 | C[C@@H](N)C(=O)N1CCN(CCCOc2ccc(C(=O)C3CC3)cc2)CC1 | https://dx.doi.org/10.1016/s0960-894x(02)00310-4 | |
A-349,821 | 99024 | None | 0 | Human | Binding | Ki | = | 10000.00 | 5.00 | -9120 | 10 | Binding affinity towards human histaminergic (H2) receptor | ChEMBL | 422.3 | 7 | 0 | 4 | 4.47 | C[C@H]1CC[C@H](C)N1CCCOc1ccc(-c2ccc(C(=O)N3CCOCC3)cc2)cc1 | https://dx.doi.org/10.1016/s0960-894x(03)00118-5 | |
A331440 | 198 | None | 23 | Human | Binding | Ki | = | 10000.00 | 5.00 | -3467 | 4 | Binding affinity to the human cortical histamine H2 receptor | ChEMBL | 349.2 | 7 | 0 | 4 | 3.63 | CN(C)[C@@H]1CCN(CCCOc2ccc(-c3ccc(C#N)cc3)cc2)C1 | https://dx.doi.org/10.1016/s0960-894x(02)00648-0 | |
ABT-239 | 229 | None | 35 | Human | Binding | pKi | None | - | 5.20 | -3548 | 4 | Unclassified | Guide to Pharmacology | 330.2 | 4 | 0 | 3 | 5.00 | C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1 | https://pubmed.ncbi.nlm.nih.gov/15608078 | |
Alpha-Dimethylhistane-alpha | 218639 | 3H-Histamine | 0 | Guinea pig | Binding | pKi | = | 0.20 | 9.70 | -6 | 3 | - | PDSP KiDatabase | 139.1 | 3 | 2 | 2 | 0.56 | CNC(C)Cc1cnc[nH]1 | - | |
AMBROXOL | 46238 | None | 57 | Human | Binding | AC50 | = | 6361.40 | 5.20 | - | 4 | Binding affinity towards human HRH2 in an in vitro assay with cellular components measured by membrane filtration | ChEMBL | 376.0 | 3 | 3 | 3 | 3.19 | Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
amiodarone | 398 | None | 47 | Human | Binding | IC50 | = | 10555.00 | 4.98 | -6 | 40 | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | ChEMBL | 645.0 | 11 | 0 | 4 | 6.94 | CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1 | - | |
amiodarone | 398 | None | 47 | Human | Binding | Ki | = | 10379.00 | 4.98 | -6 | 40 | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | ChEMBL | 645.0 | 11 | 0 | 4 | 6.94 | CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1 | - | |
amiodarone | 398 | None | 47 | Human | Binding | pKi | = | 4.98 | 8.30 | -6 | 40 | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | Drug Central | 645.0 | 11 | 0 | 4 | 6.94 | CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1 | - | |
amiodarone | 398 | None | 47 | Human | Binding | AC50 | = | 2822.20 | 5.55 | -6 | 40 | Binding affinity towards human HRH2 in an in vitro assay with cellular components measured by membrane filtration | ChEMBL | 645.0 | 11 | 0 | 4 | 6.94 | CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
amisulpride | 400 | 3H-TIOTIDINE | 72 | Human | Binding | pKi | = | 10000.00 | 5.00 | -4365 | 53 | - | PDSP KiDatabase | 369.2 | 7 | 2 | 6 | 1.28 | CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC | - |
Showing 1 to 20 of 1,038 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
4-methylhistamine | 121 | None | 34 | Human | Functional | EC50 | = | 3162.28 | 5.50 | -67 | 7 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing Gsalphas by steady-state GTPase activity assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
4-methylhistamine | 121 | None | 34 | Human | Functional | EC50 | = | 2884.03 | 5.54 | -67 | 7 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1021/jm900526h | |
amitriptyline | 401 | None | 38 | Human | Functional | pIC50 | = | 6.80 | 8.17 | -100 | 51 | None | Drug Central | 277.2 | 3 | 0 | 1 | 4.17 | CN(C)CCC=C1c2ccccc2CCc2ccccc21 | - | |
amthamine | 404 | None | 24 | Human | Functional | pEC50 | = | - | 6.40 | 57 | 4 | Unclassified | Guide to Pharmacology | 157.1 | 2 | 2 | 4 | 0.54 | Cc1nc(N)sc1CCN | https://pubmed.ncbi.nlm.nih.gov/19072936 | |
amthamine | 404 | None | 24 | Human | Functional | EC50 | = | 190.55 | 6.72 | 57 | 4 | Agonist activity at human H2R-Gsalphas expressed in Sf9 cells at 0.1 nM to 10 uM by steady state GTPase activity assay | ChEMBL | 157.1 | 2 | 2 | 4 | 0.54 | Cc1nc(N)sc1CCN | https://dx.doi.org/10.1021/jm201128q | |
ASENAPINE | 107587 | None | 16 | Human | Functional | pIC50 | = | 8.21 | 8.09 | -40 | 54 | None | Drug Central | 285.1 | 0 | 0 | 2 | 4.26 | CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 | - | |
BETAZOLE | 14503 | None | 47 | Human | Functional | AC50 | = | 910.00 | 6.04 | - | 1 | Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method | ChEMBL | 111.1 | 2 | 2 | 2 | -0.09 | NCCc1cc[nH]n1 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
bromocriptine | 729 | None | 28 | Human | Functional | AC50 | = | 2130.90 | 5.67 | -676 | 45 | Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method | ChEMBL | 653.2 | 5 | 3 | 6 | 3.19 | CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
burimamide | 743 | None | 0 | Human | Functional | pEC50 | None | - | 5.65 | - | 7 | Unclassified | Guide to Pharmacology | 262.1 | 5 | 3 | 2 | 1.98 | CNC(=S)NCCCCc1cccc2[nH]ncc12 | https://pubmed.ncbi.nlm.nih.gov/9681472 | |
cabergoline | 778 | None | 41 | Human | Functional | AC50 | = | 4230.00 | 5.37 | -891 | 19 | Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method | ChEMBL | 451.3 | 8 | 2 | 4 | 3.19 | C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
cefapirin | 220190 | None | 0 | Human | Functional | pIC50 | = | 5.24 | 8.28 | -1 | 14 | None | Drug Central | 423.1 | 7 | 2 | 8 | 0.47 | CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1 | - | |
CHEMBL1077596 | 5628 | None | 0 | Human | Functional | EC50 | = | 12022.64 | 4.92 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 321.1 | 6 | 4 | 4 | 1.15 | Cc1ccc(S(=O)(=O)NC(=N)NCCCc2c[nH]cn2)cc1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078210 | 5715 | None | 0 | Human | Functional | EC50 | = | 14125.38 | 4.85 | -18 | 2 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 310.2 | 8 | 3 | 3 | 1.99 | N#C/N=C(\NCCCc1ccccc1)NCCCc1c[nH]cn1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078212 | 5716 | None | 0 | Human | Functional | EC50 | = | 8912.51 | 5.05 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 324.2 | 9 | 3 | 3 | 2.38 | N#C/N=C(\NCCCCc1ccccc1)NCCCc1c[nH]cn1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078358 | 5738 | None | 0 | Human | Functional | EC50 | = | 1995.26 | 5.70 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 314.2 | 7 | 4 | 2 | 1.20 | NC(=O)/N=C(/NCCCc1ccccc1)NCCc1c[nH]cn1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078359 | 5739 | None | 0 | Human | Functional | EC50 | = | 436.52 | 6.36 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 328.2 | 8 | 4 | 2 | 1.59 | NC(=O)/N=C(/NCCCc1ccccc1)NCCCc1c[nH]cn1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078359 | 5739 | None | 0 | Human | Functional | EC50 | = | 645.65 | 6.19 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 328.2 | 8 | 4 | 2 | 1.59 | NC(=O)/N=C(/NCCCc1ccccc1)NCCCc1c[nH]cn1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078529 | 5765 | None | 0 | Human | Functional | EC50 | = | 7244.36 | 5.14 | -5 | 2 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 328.1 | 8 | 3 | 4 | 2.15 | N#C/N=C(/NCCCc1c[nH]cn1)NCCSc1ccccc1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078746 | 5795 | None | 0 | Human | Functional | EC50 | = | 380.19 | 6.42 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 342.2 | 9 | 4 | 2 | 1.98 | NC(=O)/N=C(/NCCCCc1ccccc1)NCCCc1c[nH]cn1 | https://dx.doi.org/10.1021/jm900526h | |
CHEMBL1078747 | 5796 | None | 0 | Human | Functional | EC50 | = | 12022.64 | 4.92 | - | 1 | Agonist activity at human histamine H2 receptor expressed in Sf9 cells coexpressing GsalphaS protein by steady-state GTPase assay | ChEMBL | 335.1 | 8 | 4 | 4 | 1.03 | N=C(NCCCc1c[nH]cn1)NS(=O)(=O)CCc1ccccc1 | https://dx.doi.org/10.1021/jm900526h |
Showing 1 to 20 of 254 entries